ERIN FRANK: Open Payments
NPI 1396129458 · HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,323 in 102 payments from 37 companies in 2025. Trend: 2023 $4,364 · 2024 $3,848 · 2025 $3,323
Food & beverage: $2,210Long term medical supply or device loan: $1,000Education: $112
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 20 | $1,179 |
| Merck Sharp & Dohme LLC | 11 | $302 |
| ABBVIE INC. | 8 | $193 |
| SEAGEN INC. | 1 | $100 |
| Janssen Biotech, Inc. | 3 | $91 |
| Eisai Inc. | 3 | $87 |
| PFIZER INC. | 3 | $76 |
| BeOne Medicines USA, Inc. | 3 | $76 |
| ARRAY BIOPHARMA INC | 3 | $75 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $72 |
Products named: KISQALI, KEYTRUDA, IMBRUVICA, Lenvima, BRUKINSA, Nubeqa, BESREMI, IMFINZI.
Industry payments across CT — which companies pay providers there.
